EP06.05. Computational Pathology-Based Assessment of cMET IHC Expression for Patient Selection in the Treatment of MET Overexpressing NSCLC - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Simon Christ
Meta Tag
Speaker Simon Christ
Topic Pathology & Biomarkers
computational pathology-based assessment
cMET IHC expression
MET overexpressing non-small cell lung cancer
EGFR tyrosine kinase inhibitors
histologic examination
immunohistochemically stained tissue
Quantitative Continuous Scoring (QCS)
MET expression
SAVANNAH clinical trial
progression-free survival (mPFS)
Powered By